Robert L Hoffman

4PUBLICATIONS
33CO-AUTHORS
Proteins and peptidesMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 19, 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.

Britton Boras, Rhys M Jones, Brandon J Anson

|Jun 10, 2021
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer.

Kevin D Freeman-Cook, Robert L Hoffman, Douglas C Behenna

|Oct 15, 2020
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19.

Robert L Hoffman, Robert S Kania, Mary A Brothers

|Sep 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19.

Britton Boras, Rhys M Jones, Brandon J Anson

Pageof 1